Last updated: 11/03/2018 11:03:34

Effectiveness of human rotavirus vaccine, Rotarix™ against rotavirus severe gastroenteritis (RV SGE) in infants

GSK study ID
110467
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Case-control study to evaluate the vaccine effectiveness of Rotarix™ against rotavirus severe gastroenteritis (RV SGE) among hospitalised children < 5 years of age in KK Hospital, Singapore
Trial description: This study aims to evaluate the effectiveness of Rotarix™ vaccine in the general population in Singapore by monitoring the overall reduction in RV SGE and also by assessing the direct protection offered by the vaccine in hospitalised infants through a case-control study.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

To estimate the proportion of acute RV GE hospitalisations in children < 5 years of age.

Timeframe: At least one year

To estimate the effectiveness of two doses of Rotarix™ vaccination in preventing rotavirus severe gastroenteritis (RV SGE) among children born after 1 November 2005 and aged at least 16 weeks.

Timeframe: At least one year

Secondary outcomes:

To estimate the effectiveness of two doses of Rotarix™ vaccination in preventing hospitalisation for acute RV GE among children born after 1 November 2005 and aged at least 16 weeks.

Timeframe: At least one year

To determine the distributions of acute RV GE associated hospital admissions according to subject's age, gender and by month of year.

Timeframe: At least one year

To estimate the prevalence of RV genotypes in acute RV GE associated hospital admission.

Timeframe: At least one year

To review the trend of acute RV GE and acute GE admissions over the entire study period.

Timeframe: At least one year

Interventions:
  • Other: Collection of information
  • Procedure/surgery: Collection of stool samples
  • Enrollment:
    1270
    Primary completion date:
    2010-08-07
    Observational study model:
    Case-Control
    Time perspective:
    Prospective
    Clinical publications:
    Not applicable
    Medical condition
    Rotavirus severe gastroenteritis
    Product
    SB444563
    Collaborators
    Not applicable
    Study date(s)
    April 2008 to July 2010
    Type
    Observational
    Phase
    Not applicable

    Participation criteria

    Sex
    Female & Male
    Age
    - 5 years
    Accepts healthy volunteers
    No
    • Inclusion criteria for surveillance subjects
    • A male or female child aged < 60 months at the time of admission (a child becomes ineligible on the day of its fifth birthday).
    • For enrolment of surveillance subjects
    • The following criteria should be checked at the time of study entry. If any apply, the subject must not be included in the study:

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Singapore, Singapore, 229899
    Status
    Study Complete

    Study documents

    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    2010-08-07
    Actual study completion date
    2010-08-07

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website